Transforming growth factor beta1 up-regulates interferon regulatory factor 8 during dendritic cell development

Xin-Sheng Ju1, David Ruau, Piritta Jäntti

  • 1Institute for Biomedical Engineering, Department of Cell Biology, Aachen University Hospital, Aachen, Germany.

Insights

Transforming growth factor beta1 (TGF-beta1) signaling directly regulates interferon regulatory factor 8 (IRF-8) in dendritic cells (DC). This pathway impacts DC function and migration by influencing CCR7 expression.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Langerhans cells (LC) are key dendritic cells (DC) in the skin.
  • LC development requires transforming growth factor beta1 (TGF-beta1), as TGF-beta1 knockout mice lack LC.

Purpose of the Study:

  • To identify novel TGF-beta1 target genes in dendritic cells (DC).
  • To elucidate the molecular mechanisms by which TGF-beta1 influences DC phenotype and function.

Main Methods:

  • Utilized a two-step cell culture system for dendritic cells (DC).
  • Employed transcriptional profiling via DNA microarrays to identify target genes.
  • Investigated signaling pathways using Smad7 expression and SB431542 inhibitor.

Main Results:

  • Identified interferon regulatory factor 8 (IRF-8) as a direct TGF-beta1 target gene in DC.
  • Demonstrated TGF-beta1 induces Smad2/3 phosphorylation and IRF-8 expression, independent of protein synthesis.
  • Showed TGF-beta1 upregulates chemokine receptor CCR7 and enhances DC migration, a process involving IRF-8.

Conclusions:

  • A novel TGF-beta1/Smad/IRF-8 signaling pathway regulating DC function was identified.
  • This pathway is crucial for CCR7 expression and DC migration.
  • IRF-8 plays a significant role in mediating TGF-beta1's effects on DC phenotype and migration.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...